Serum retinol binding protein 4 indicates the overlapping molecular manisfestaion of insulin resistance in dyslipidemia/T2DM/obesity, and thus provides further evidence for a protective effect of metabolic disorders in ALS [148]. The gene discussed is RBP4; the disease is amyotrophic lateral sclerosis.